APYX Logo

Apyx Medical Corporation (APYX) 

NASDAQ
Market Cap
$53.08M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
305 of 774
Rank in Industry
41 of 99

Largest Insider Buys in Sector

APYX Stock Price History Chart

APYX Stock Performance

About Apyx Medical Corporation

Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ablate soft tissue during open and laparoscopic surgical procedures. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and …

Insider Activity of Apyx Medical Corporation

Over the last 12 months, insiders at Apyx Medical Corporation have bought $11,505 and sold $0 worth of Apyx Medical Corporation stock.

On average, over the past 5 years, insiders at Apyx Medical Corporation have bought $60,352 and sold $113,400 worth of stock each year.

Highest buying activity among insiders over the last 12 months: HILL MATTHEW C (Chief Financial Officer) — $34,514.

The last purchase of 5,336 shares for transaction amount of $6,030 was made by HILL MATTHEW C (Chief Financial Officer) on 2024‑08‑13.

List of Insider Buy and Sell Transactions, Apyx Medical Corporation

2024-08-13PurchaseChief Financial Officer
5,336
0.0163%
$1.13$6,0300.00%
2023-12-12PurchaseChief Financial Officer
2,500
0.0071%
$2.19$5,475-35.27%
2023-11-14PurchaseChief Executive Officer
50,000
0.1498%
$1.57$78,500-4.46%
2023-06-26SaleExecutive Vice President
15,000
0.0434%
$7.56$113,400-69.14%
2022-08-29PurchaseChief Executive Officer
9,750
0.0286%
$5.97$58,208-30.53%
2020-05-13PurchaseChief Executive Officer
28,250
0.0829%
$3.30$93,197+101.67%
2016-08-17PurchaseChief CommercializationOfficer
181,500
0.2685%
$3.30$598,950
2015-12-22PurchaseChief Commercialization Office
50,000
0.0443%
$1.98$98,855
2015-12-21PurchaseSr. V.P. of Operations
40,000
0.033%
$1.84$73,548
2015-12-21PurchaseChief Executive Officer
20,000
0.0163%
$1.82$36,336
2015-08-14PurchaseChief Executive Officer
40,000
0.0429%
$2.39$95,600
2011-12-23Saledirector
1,500
0.0016%
$2.40$3,600
2011-08-25Purchasedirector
14,200
0.0172%
$2.70$38,340
2011-08-24Purchasedirector
28,200
0.0337%
$2.66$75,063
2011-08-23Purchasedirector
23,200
0.0265%
$2.55$59,160
2011-08-09Purchase10 percent owner
230,000
0.2478%
$2.40$552,700
2011-06-08Saledirector
10,000
0.0129%
$2.87$28,700
2011-05-20Saledirector
1,600
0.0021%
$2.99$4,784
2011-03-07Purchase10 percent owner
300,000
0.3456%
$2.57$771,000
2010-12-03Saledirector
12,156
0.0168%
$3.08$37,440

Insider Historical Profitability

35.57%
HILL MATTHEW CChief Financial Officer
7836
0.0208%
$1.4120
RENN Universal Growth Investment Trustdirector
1247800
3.3147%
$1.4150
CITRONOWICZ MOSHESr. V.P. of Operations
426504
1.133%
$1.41112
McCarthy John J. IIIChief CommercializationOfficer
115750
0.3075%
$1.4120
Goodwin Charles D. IIChief Executive Officer
90000
0.2391%
$1.4130+35.57%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Archon Capital Management Llc$4.69M9.963.45M0%+$00.1
ROYCE & ASSOCIATES INC$3.31M7.032.44M+12.87%+$377,752.210.03
The Vanguard Group$2.01M4.281.48M0%+$0<0.0001
Taylor Frigon Capital Management LLC$867,286.001.84637,710-0.2%-$1,706.800.12
Horizon Kinetics LLC$836,400.001.78615,0000%+$00.01
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.